VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress E Karali, S Bellou, D Stellas, A Klinakis, C Murphy, T Fotsis Molecular cell 54 (4), 559-572, 2014 | 192 | 2014 |
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer AK Najumudeen, F Ceteci, SK Fey, G Hamm, RT Steven, H Hall, ... Nature genetics 53 (1), 16-26, 2021 | 139 | 2021 |
Metabolic fingerprinting links oncogenic PIK3CA with enhanced arachidonic acid-derived eicosanoids N Koundouros, E Karali, A Tripp, A Valle, P Inglese, NJS Perry, DJ Magee, ... Cell 181 (7), 1596-1611. e27, 2020 | 93 | 2020 |
Direct binding of Bcl-2 family proteins by quercetin triggers its pro-apoptotic activity A Primikyri, MV Chatziathanasiadou, E Karali, E Kostaras, MD Mantzaris, ... ACS chemical biology 9 (12), 2737-2741, 2014 | 78 | 2014 |
Universal sample preparation unlocking multimodal molecular tissue imaging A Dannhorn, E Kazanc, S Ling, C Nikula, E Karali, MP Serra, JL Vorng, ... Analytical Chemistry 92 (16), 11080-11088, 2020 | 67 | 2020 |
The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth S Bellou, E Karali, E Bagli, N Al-Maharik, L Morbidelli, M Ziche, ... Molecular cancer 11, 1-11, 2012 | 44 | 2012 |
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer J Antony, E Zanini, Z Kelly, TZ Tan, E Karali, M Alomary, Y Jung, K Nixon, ... EMBO reports 19 (8), e45670, 2018 | 38 | 2018 |
The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR-and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer E Zanini, LS Louis, J Antony, E Karali, IS Okon, AB McKie, S Vaughan, ... Molecular Cancer Therapeutics 16 (10), 2246-2256, 2017 | 31 | 2017 |
Four new depsides in Origanum dictamnus methanol extract V Exarchou, PG Takis, M Malouta, J Vervoort, E Karali, AN Troganis Phytochemistry letters 6 (1), 46-52, 2013 | 16 | 2013 |
VEGF signaling, mTOR complexes, and the endoplasmic reticulum: towards a role of metabolic sensing in the regulation of angiogenesis E Karali, S Bellou, D Stellas, A Klinakis, C Murphy, T Fotsis Molecular & Cellular Oncology 1 (3), e964024, 2014 | 15 | 2014 |
Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions JR Birtley, M Alomary, E Zanini, J Antony, Z Maben, GC Weaver, ... Nature communications 10 (1), 3134, 2019 | 13 | 2019 |
Vitamin B5 supports MYC oncogenic metabolism and tumor progression in breast cancer P Kreuzaler, P Inglese, A Ghanate, E Gjelaj, V Wu, Y Panina, ... Nature Metabolism 5 (11), 1870-1886, 2023 | 8 | 2023 |
A multimodal analysis in breast cancer: Revealing metabolic heterogeneity using DESI-MS imaging with Laser-microdissection coupled transcriptome approach. E Kazanc, E Karali, V Wu, P Inglese, J McKenzie, A Tripp, N Koundouros, ... CANCER RESEARCH 80 (21), 2020 | | 2020 |
Near Real-time Stratification of PIK3CA Mutant Breast Cancers Using the iKnife N Koundouros, A Tripp, E Karali, A Valle, P Inglese, S Anjomani-Virmouni, ... John Wiley & Sons, Ltd. on behalf of Pathological Society of Great Britain …, 2019 | | 2019 |
Decoding The BH3-Mimetic Pro-Apoptotic Activity Of Quercetin In Jurkat Cells A Primikyri, E Hatzimichael, E Karali, E Kostaras, M Manztaris, JS Shin, ... Blood 122 (21), 1672, 2013 | | 2013 |
FLAVONOIDS SUPPRESS TUMOUR ANGIOGENESIS BY INHIBITING VEGF SIGNALLING S Bellou, E Bagli, E Karali, C Murphy, Fotsis EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 50, E16-E16, 2013 | | 2013 |
Λειτουργικός χαρακτηρισμός γονιδίων τα οποία ρυθμίζονται από τον VEGF (Vascual Endothelial Growth Factor) Ε Καραλή | | 2012 |